COMMUNIQUÉS West-GlobeNewswire

VuduMobile launches its new website

23/07/2018 - 15:00

MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (“A TW Tech ” or the “Company”) (TSX-V:ATW) announces today the launch of a new website for its wholly-owned subsidiary, VuduMobile Inc. (‘VuduMobile’). ATW Tech [...]

VuduMobile lance son nouveau site web

23/07/2018 - 15:00

MONTRÉAL, 23 juill. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (« ATW Tech » ou la « Société ») (TSX-V:ATW) annonce aujourd’hui le lancement de son nouveau site web pour sa filiale exclusive VuduMobile Inc. (‘VuduMobile’). [...]

Empower Clinics Positioned as Cannabis Disrupts Pharmaceutical Industry -- CFN Media

23/07/2018 - 15:00

SEATTLE, July 23, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]

News Release - Aspri Pharma Canada Inc. Announces Acquisition of Convertible Debentures of Devonian Health Group Inc.

23/07/2018 - 14:56

CONCORD, Ontario, July 23, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc. (“ Aspri ”), a pharmaceutical products wholesale and manufacturer corporation, announces that on July 19, 2018, it has subscribed for [...]

Canada House Wellness Group’s Licensed Cannabis Producer Abba Medix Receives First Sales License from Health Canada

23/07/2018 - 14:52

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 23, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]

CV Sciences, Inc. Files Application for Up-Listing to the NASDAQ Capital Market

23/07/2018 - 14:45

LAS VEGAS, July 23, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including cannabidiol (CBD) oil and developer of specialty [...]

SELLAS To Present Data from Phase 2b Trial of NeuVax + Herceptin® at Upcoming European Society for Medical Oncology (ESMO) 2018 Meeting

23/07/2018 - 14:40

Oral Presentation of NeuVax + Herceptin in the Adjuvant Treatment of Triple-Negative Breast Cancer Conference Scheduled for October 19-23, 2018 in Munich, Germany NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- SELLAS Life [...]

OraSure Technologies, Inc. Appoints Vice President, Corporate Communications

23/07/2018 - 14:34

BETHLEHEM, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostics and specimen collection devices, today announced that Jeanne Mell has been appointed as [...]

Scythian Biosciences Corp. Announces Strategic Partnership for Cannabis in Brazil with one of the Founders of the Country’s Pharma Industry

23/07/2018 - 14:34

Company Strategically Positioned to Lead the Future of Cannabis for Medicinal Purposes for Brazil’s More Than 200 Million Population TORONTO, July 23, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (to be renamed [...]

Histogenics Chief Operating Officer, Stephen Kennedy Appointed to Advanced Regenerative Manufacturing Institute’s Technology Advisory Sub-Committee

23/07/2018 - 14:30

WALTHAM, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored [...]

Rubius Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

23/07/2018 - 14:30

CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced the [...]

CFN Media Launches Inaugural Episode of CFN Weekly

23/07/2018 - 14:30

SEATTLE, July 23, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces the launch of a new weekly news show [...]

MedTainer Orders Continue to Grow; More LPs Choosing Acology

23/07/2018 - 14:30

CORONA, Calif., July 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) announced today that orders for its signature product, the MedTainer™, continue to increase beyond the record pace set for the same [...]

Allena Pharmaceuticals Announces First Patients Treated in Phase 2 Basket Study of ALLN-177 in Patients with Primary Hyperoxaluria or Enteric Hyperoxaluria and Advanced Chronic Kidney Disease

23/07/2018 - 14:00

U.S. Clinical Study Sites Enrolling Patients with Systemic Oxalate Burden; European Sites Prepared to Enroll Patients in Third Quarter of 2018 NEWTON, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc [...]

Brooke Donaldson, MD is Appointed to the American Health Council’s Board of Physicians

23/07/2018 - 14:00

NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) -- Brooke Donaldson, MD has been appointed to the American Health Council’s Board of Physicians. Dr. Donaldson currently serves as the Genesis Peer Support clinical chairwoman, [...]

Immunomedics Announces Clinical Collaboration With AstraZeneca in First-Line Triple-Negative Breast and Urothelial Cancers

23/07/2018 - 14:00

Phase 1/2 Studies will Evaluate the Combination of Imfinzi® (Durvalumab) and Sacituzumab Govitecan in Previously-Untreated Patients with Triple-negative Breast Cancer and Urothelial Cancer MORRIS PLAINS, N.J., July 23, [...]

PetMed Express D/B/A 1-800-PetMeds Announces Record Earnings for Its First Fiscal Quarter and Its Increased Quarterly Dividend of $0.27 Per Share

23/07/2018 - 14:00

First Quarter Net Income Increased 36% First Quarter Sales Increased 10% First Quarter Diluted EPS $0.62 per share vs $0.45 per share DELRAY BEACH, Fla., July 23, 2018 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: [...]

Savara to Ring Nasdaq Stock Market Opening Bell on July 23rd

23/07/2018 - 14:00

AUSTIN, Texas, July 23, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq:SVRA), an orphan lung disease company, announced today that Rob Neville, CEO of Savara, alongside key members of senior management, company directors [...]

ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431

23/07/2018 - 14:00

Data from the First Patient Cohort Indicate CRV431 is Safe and Well Tolerated EDISON, N.J., July 23, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the [...]